Standout Papers

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-do... 1995 2026 2005 2015 1.0k
  1. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. (1995)
    G. Fyfe, Richard I. Fisher et al. Journal of Clinical Oncology

Immediate Impact

10 by Nobel laureates 11 from Science/Nature 57 standout
Sub-graph 1 of 16

Citing Papers

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
2021 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
4 intermediate papers

Works of G. Fyfe being referenced

High-dose aldesleukin in renal cell carcinoma: long-term survival update.
1997
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
1995 Standout

Author Peers

Author Last Decade Papers Cites
G. Fyfe 1183 515 1023 831 19 2.7k
A. John Iafrate 922 492 851 455 53 2.6k
Byron M. Espina 1597 105 1014 430 73 3.4k
Rachel Humphrey 4106 154 1024 2039 50 5.2k
Stephanie Lustgarten 781 303 2055 149 60 3.5k
Aby Buchbinder 843 723 218 1618 55 4.2k
I. Funke 1939 75 635 571 35 3.3k
Poonam Mannan 295 234 259 521 22 1.9k
Carla S. Wilson 1631 95 188 456 36 4.2k
Catherine K. Chow 1017 74 481 830 39 2.6k
Richard J. Bende 467 599 143 1271 51 3.2k

All Works

Loading papers...

Rankless by CCL
2026